April 08, 2021 2:12 PM
AstraZeneca said it was working with regulators to list possible brain blood clots as “an extremely rare potential side effect”.
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%Accept